The 3rd US Circuit Court of Appeals upheld Medicare's authority to negotiate drug prices, affecting Novo Nordisk's insulin products. The Inflation Reduction Act includes drug rebates, price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback